Patents by Inventor Peter M. Larsen

Peter M. Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925356
    Abstract: An example medical device for occluding the left atrial appendage includes an expandable member having a first end region, a second end region and an inflation cavity. The medical device also includes a plurality of spine members coupled to the expandable member, the plurality of spine members spaced circumferentially around an outer surface of the expandable member. Additionally, the medical device includes a valve member extending at least partially into the inflation cavity, wherein the plurality of spine members are configured to position the medical device within an opening of the left atrial appendage and wherein the expandable member is configured to expand and seal the opening of the left atrial appendage.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: March 12, 2024
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: James M. Anderson, John M. Edgell, Jose A. Meregotte, Steven R. Larsen, David Raab, Peter John Hoffman, David John Onushko
  • Patent number: 7655471
    Abstract: Endometrium secreted polypeptides are assayed in body fluids to determine the presence of polypeptides of specified pI and MW values that have been found to be regulated in body fluids according to the status of the endometrium, or the presence of hyperplasia or adenocarcinoma.
    Type: Grant
    Filed: January 17, 2003
    Date of Patent: February 2, 2010
    Assignee: Drugmode APS
    Inventors: Inger Byrjalsen, Peter M. Larsen, Stephen J. Fey
  • Publication number: 20030044795
    Abstract: Assay methods are provided for detection or quantitation of any of several proteins which are specifically produced in the endometrium in association with hyperplasia, adenocarcinoma or the proliferative phase of the endometrium. The relevant proteins have been identified by 2D gel electrophoresis with subsequent sequence identification by mass spectroscopic finger printing of tryptic digests.
    Type: Application
    Filed: August 24, 2001
    Publication date: March 6, 2003
    Inventors: Inger Byrajalsen, Peter M. Larsen, Stephen J. Fey